Workstreams

Viewing related articles

Reflections on Covid-19 inbound supply chain issues

Reflections on Covid-19 inbound supply chain issues

LONG READReflections on Covid-19 inbound supply chain issuesCovid-19 has had a significant impact throughout the biopharmaceutical industry, not least on the inbound supply chain, which has been hit by issues such as restricted supplies, the need for new sourcing strategies and how to design and build new facilities. To assess the issues, major supply partners (MSPs) were invited to submit questions to the biomanufacturing members of the Senior...

read more
Harmonizing the industry and improving confidence through risk-based microbial testing

Harmonizing the industry and improving confidence through risk-based microbial testing

LONG READHarmonizing the industry and improving confidence through risk-based microbial testingThe integrity of microbiological test data is critically important to ensure the safety of both the pharmaceutical products and the patients who receive them. One approach to ensure the quality of drug products is to implement second-person verification of microbial testing; however, requiring second-person verification of all data is time-consuming...

read more
IDBS Joins BioPhorum – Global Biopharma Collaboration dedicated to accelerating the rate of industry progress

IDBS Joins BioPhorum – Global Biopharma Collaboration dedicated to accelerating the rate of industry progress

Guildford, UK — October 20, 2021 — IDBS, the leading innovator in BioPharma Lifecycle Management (BPLM), announces its membership of BioPhorum. BioPhorum offers a space where biopharmaceutical manufacturers and suppliers can come together and discuss the many challenges in the industry, working collaboratively to address them. IDBS has joined the Information Technology Phorum (BPIT) which specifically addresses IT business goals. While the...

read more
The Spontaneous Infection: Did you leave the back door to your cultivation suite open?

The Spontaneous Infection: Did you leave the back door to your cultivation suite open?

In Shared clean-in-place systems: To share or not to share? and How much harm can a single droplet do? Considerations for a viral inactivation step, BioPhorum’s Drug Substance Closed Systems in CNC workstream addressed viral segregation of manufacturing steps relating to the purification process. In this follow-up paper, published by BioProcess International, the workstream looks more closely at viral contamination risks related to perhaps the...

read more